New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 - Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to support new and innovative epidemiology research in heart, lung, blood, and/or sleep diseases, disorders, and/or phenotypes. Through this FOA, the National Heart, Lung, and Blood Institute (NHLBI) aims to establish a new epidemiology cohort of at least 2000 participants to stimulate research on a wide range of heart, lung, blood, and/or sleep research hypotheses.

Deadlines:

  • Letter of Intent:¬†30 days prior to the application due date
  • Application Due Date(s):¬†June 5, 2018, June 5, 2020

PAR-18-577 Expiration Date June 6, 2020

Agency Website

Amount Description

As a guidance, application budgets should not exceed $1.948 million in direct costs in the first year of the project period, and should not exceed $3.896 million in direct costs in any subsequent year of the project period.

Application budgets should reflect the actual needs of the proposed project.

Funding Type

Grant

Eligibility

Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Social Sciences

External Deadline

June 5, 2020